Northwestern Mutual Wealth Management Co. Acquires 23,150 Shares of Invesco Pharmaceuticals ETF $PJP

Northwestern Mutual Wealth Management Co. increased its position in shares of Invesco Pharmaceuticals ETF (NYSEARCA:PJP) by 829.5% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 25,941 shares of the company’s stock after purchasing an additional 23,150 shares during the period. Northwestern Mutual Wealth Management Co.’s holdings in Invesco Pharmaceuticals ETF were worth $2,712,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently modified their holdings of the company. International Assets Investment Management LLC bought a new stake in shares of Invesco Pharmaceuticals ETF during the 4th quarter valued at $64,000. Mirae Asset Global Investments Co. Ltd. bought a new stake in shares of Invesco Pharmaceuticals ETF during the 4th quarter valued at $167,000. CIBC Bancorp USA Inc. bought a new stake in shares of Invesco Pharmaceuticals ETF during the 3rd quarter valued at $203,000. Jones Financial Companies Lllp raised its position in shares of Invesco Pharmaceuticals ETF by 11.6% during the 1st quarter. Jones Financial Companies Lllp now owns 2,428 shares of the company’s stock valued at $210,000 after purchasing an additional 252 shares during the period. Finally, Tower Research Capital LLC TRC raised its position in shares of Invesco Pharmaceuticals ETF by 102.9% during the 2nd quarter. Tower Research Capital LLC TRC now owns 4,680 shares of the company’s stock valued at $374,000 after purchasing an additional 2,374 shares during the period.

Invesco Pharmaceuticals ETF Price Performance

Shares of PJP stock opened at $109.05 on Tuesday. The company has a market capitalization of $356.59 million, a price-to-earnings ratio of 15.59 and a beta of 0.46. Invesco Pharmaceuticals ETF has a one year low of $78.25 and a one year high of $110.81. The company’s fifty day moving average price is $104.49 and its 200-day moving average price is $105.28.

Invesco Pharmaceuticals ETF Profile

PowerShares Dynamic Pharmaceuticals Portfolio (the Fund) is a non-diversified fund. The Fund seeks investment results that correspond generally to the price and yield of the Dynamic Pharmaceuticals Intellidex Index (the Index). The Index evaluates companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors. The Index consists of stocks of 30 United States pharmaceutical companies. These are companies that are principally engaged in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types.